{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025966","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2025-12-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.847714+00:00","generated_at":"2026-05-16T15:25:47.977495+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"ZyVersa director Robert Finizio resigns from board effective Dec 2, 2025","bullets":["Independent director Robert G. Finizio resigned as board member, Compensation Committee chair, and Audit Committee member.","Resignation effective immediately on December 2, 2025; accepted by the Board.","Resignation was for personal reasons, not due to any disagreement with the Company on operations, policies, or practices.","No replacement has been announced for the vacated board or committee positions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025966","json":"https://secwatch.observer/filing/0001493152-25-025966.json","markdown":"https://secwatch.observer/filing/0001493152-25-025966.md","text":"https://secwatch.observer/filing/0001493152-25-025966.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315225025966/0001493152-25-025966-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315225025966/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:25:47.977495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}